Melola Discovery

← Melola Discovery

Akses terbuka Jurnal SINTA 1

NT-proBNP LEVEL CHANGES AFTER COMBINATION THERAPY WITH BISOPROLOL AND ACE-INHIBITOR IN PATIENT WITH HEART FAILURE

Folia Medica Indonesiana · Vol. 52 No. 4 (2017) · hlm. 258–258

DOI
10.20473/fmi.v52i4.5472
ISSN
2355-8393, 2599-056X
Terbit
2017-08-14
Penerbit
Airlangga University
Bahasa
en
Lisensi
creativecommons.org/licenses/by-nc-sa/4.0/

Abstrak

Heart failure (HF) is the final common stage of many diseases of the heart. NT-proBNP levels are increased in HF and correlate well with ventricular wall stress and severity of HF. Combination therapy with Bisoprolol and ACE-inhibitor decreases NT-proBNP level in patient with HF. The use of Bisoprolol as a combination with ACE-inhibitor is still dominate in outpatient setting at Dr. Soetomo teaching hospital. The objective of this study is to analyze NT-proBNP level changes as an indicator in cardiac function after combination therapy with Bisoprolol and ACE-inhibitor in patient with HF.Methods: This study was prospective, observational and conducted in outpatient setting. Consecutive patients who meet the inclusion criteria of the study were included. Blood samples were taken at pre and 2 months post combination therapy with Bisoprolol and ACE-inhibitor, then NT-proBNP level was measured with IMMULITE®. There were 14 patients enrolled in this study (7 males, 7 females). The result showed that NT-proBNP 2 months post combination therapy with Bisoprolol and ACE-inhibitor is significantly decreased than baseline with mean baseline of NT-proBNP level is 4191.43 ± 4367.277 pg/ml to 2786.79 ± 2485.199 pg/ml (p=0.025). From a total 14 patients, 9 patients had NT-proBNP decreases >20% (20.1% – 56.4%) and 3 patients had NT-proBNP decreases 40% (43.4% and 40.4%). In conclusion, there was a significant decreases in NT-proBNP level after 2 months combination therapy with Bisoprolol and ACE-inhibitor in patient with HF.

Kata kunci

Jaringan kolaborasi para penulis

40 penulis · 91 tautan kepenulisan bersama · 36 lintas organisasi · menampilkan 40 yang paling banyak terhubung

Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.

  • University of Brawijaya
  • Universitas Airlangga
  • Kanazawa University
  • Lambung Mangkurat University
  • Rumah Sakit Dokter Soetomo
  • Tanjungpura University
  • Hasanuddin University
  • Organisasi lain
  • Afiliasi tidak diketahui
  • Organisasi berbeda
  • Organisasi sama
  • Afiliasi tidak diketahui
  • Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Rekan penulisOrganisasiArtikel bersama
Tri ArdyatiUniversity of Brawijaya3
Makoto OeKanazawa University2
Erlin IfadahKanazawa University2
Bambang Subakti ZulkarnainUniversitas Airlangga2
Jusak NugrahaUniversitas Airlangga2
Amika YamadaKanazawa University1
Mukai KanaeKanazawa University1
Sukarni SukarniTanjungpura University1
Kanae MukaiKanazawa University1
Hasria AlangHasanuddin University1
Joni KusnadiUniversity of Brawijaya1
Try ArdyatiAfiliasi tidak diketahui1
Evi OctavianyUniversity of Brawijaya1
Irfan MustafaUniversity of Brawijaya1
Fatchiyah FatchiyahUniversity of Brawijaya1
Bambang SetiawanLambung Mangkurat University1
Takeshi OhtaJapan Tobacco (Japan)1
Vita AgustinaUniversity of Brawijaya1
Muhammad Darwin PrenggonoLambung Mangkurat University1
Ratih Pratiwi SariUniversitas Airlangga1
Aditya Maulana Perdana PutraLambung Mangkurat University1
Mahardian RahmadiUniversitas Airlangga1
Bagyo YanuwiadiUniversity of Brawijaya1
Agus NurrofikUniversity of Brawijaya1
Muhammad FathoniUniversity of Brawijaya1
Nia KurniawanUniversity of Brawijaya1
Miftah Farid AssiddiqyUniversity of Brawijaya1
Abdul Mutholib ShahroniUniversity of Brawijaya1
Agustin Krisna WardaniUniversity of Brawijaya1
Ekwan Nofa WiratnoUniversity of Brawijaya1
Catur RetnaningdyahUniversity of Brawijaya1
Dian AliviyantiUniversity of Brawijaya1
Fitriana RahmawatiUniversity of Brawijaya1
Elok ZubaidahUniversity of Brawijaya1
Eka Pratiwi TenriawaruUniversitas Cokroaminoto Palopo1
Fira SorayaUniversitas Airlangga1
Elyana AsnarUniversitas Airlangga1

Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.

Sumber metadata: OpenAlex API (jurnal SINTA, ADR 0048) https://openalex.org/S4210179714, pertama di-harvest 19 Nov 2026, terakhir terlihat 19 Nov 2026.
Metadata asli (oai_dc)
<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"><dc:title xml:lang="en">NT-proBNP LEVEL CHANGES AFTER COMBINATION THERAPY WITH BISOPROLOL AND ACE-INHIBITOR IN PATIENT WITH HEART FAILURE</dc:title><dc:creator>Reine Risa Risthanti</dc:creator><dc:creator>Muhammad Aminuddin</dc:creator><dc:creator>Suharjono Suharjono</dc:creator><dc:subject>NT-proBNP</dc:subject><dc:subject>heart failure</dc:subject><dc:subject>bisoprolol</dc:subject><dc:subject>ACE inhibitors</dc:subject><dc:subject>combination therapy</dc:subject><dc:subject>cardiac biomarkers</dc:subject><dc:subject>cardiac function</dc:subject><dc:description xml:lang="en">Heart failure (HF) is the final common stage of many diseases of the heart. NT-proBNP levels are increased in HF and correlate well with ventricular wall stress and severity of HF. Combination therapy with Bisoprolol and ACE-inhibitor decreases NT-proBNP level in patient with HF. The use of Bisoprolol as a combination with ACE-inhibitor is still dominate in outpatient setting at Dr. Soetomo teaching hospital. The objective of this study is to analyze NT-proBNP level changes as an indicator in cardiac function after combination therapy with Bisoprolol and ACE-inhibitor in patient with HF.Methods: This study was prospective, observational and conducted in outpatient setting. Consecutive patients who meet the inclusion criteria of the study were included. Blood samples were taken at pre and 2 months post combination therapy with Bisoprolol and ACE-inhibitor, then NT-proBNP level was measured with IMMULITE®. There were 14 patients enrolled in this study (7 males, 7 females). The result showed that NT-proBNP 2 months post combination therapy with Bisoprolol and ACE-inhibitor is significantly decreased than baseline with mean baseline of NT-proBNP level is 4191.43 ± 4367.277 pg/ml to 2786.79 ± 2485.199 pg/ml (p=0.025). From a total 14 patients, 9 patients had NT-proBNP decreases &gt;20% (20.1% – 56.4%) and 3 patients had NT-proBNP decreases &lt;20% (1.8%, 6.6%, and 12.4%). There were 2 patients with NT-proBNP increases &gt;40% (43.4% and 40.4%). In conclusion, there was a significant decreases in NT-proBNP level after 2 months combination therapy with Bisoprolol and ACE-inhibitor in patient with HF.</dc:description><dc:publisher>Airlangga University</dc:publisher><dc:date>2017-08-14</dc:date><dc:type>info:eu-repo/semantics/article</dc:type><dc:format>application/pdf</dc:format><dc:identifier>https://doi.org/10.20473/fmi.v52i4.5472</dc:identifier><dc:identifier>10.20473/fmi.v52i4.5472</dc:identifier><dc:source>Folia Medica Indonesiana; Vol 52 No 4 (2017); 258-258</dc:source><dc:source>2355-8393</dc:source><dc:source>2599-056X</dc:source><dc:language>en</dc:language><dc:relation>https://e-journal.unair.ac.id/FMI/article/download/5472/3369</dc:relation><dc:rights>https://creativecommons.org/licenses/by-nc-sa/4.0/</dc:rights></oai_dc:dc>